"Kirill Afonin and Brittany Johnson, researchers in the Klein College of Science, with colleagues from the National Cancer Institute and National Center for Advancing Translational Sciences, have developed AI-Cell (Artificial Intelligence-Cell) — a first-of-its-kind tool that mimics how immune cells respond to RNA- and DNA-based nanomedicines. Their innovation has the potential to revolutionize gene therapy, making it safer and more personalized."